Recruiting Anemia Studies in Stanford
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems....
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
BMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated....
About Anemia Clinical Trials in Stanford
Anemia is a condition in which the blood lacks adequate healthy red blood cells to carry sufficient oxygen to tissues. Iron deficiency is the most common cause, affecting over 1.6 billion people worldwide. Treatment depends on the cause and may include iron supplementation, B12, or treating underlying conditions.
There are currently 2 anemia clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 10,059 participants. Research is being sponsored by New York Blood Center, Medical College of Wisconsin. Clinical trial participation is free and participants receive study-related medical care at no cost.
Anemia Clinical Trials in Stanford — FAQ
Are there anemia clinical trials in Stanford?
Yes, there are 2 anemia clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What anemia treatments are being tested?
The 2 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for anemia.
Data updated March 2, 2026 from ClinicalTrials.gov